Rapport Therapeutics develops small molecule drugs for neurological and psychiatric disorders, led by a candidate for focal onset seizures. It last closed at $23.16 on Nov 20, down 1.82% on the day. The next earnings report for RAPP is expected around Tue, Mar 9, 2027. For the quarter ended Sep 2026, RAPP reported EPS of -$0.84 on revenue of $0. Over its last 8 reports the stock moved an average of 4.1% the session after earnings. Over the last 12 months RAPP insiders bought $22.0M of stock on the open market and sold $46.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is RAPP in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold RAPP.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on RAPPStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
RAPP · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 8% below its 20 day and 29% below its 50 day average. It is 53% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 37), near oversold. The nearest support is the swing low (Nov 6) at $22.95, and the nearest resistance the Pivot at $23.33.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityNormal, 8.1%/day
Key levels
$52.9352 week high+128.5%
$37.22100 day average+60.7%
$35.51200 day average+53.3%
$29.8550 day average+28.9%
$26.36Swing high (Nov 4)+13.8%
$24.9520 day average+7.7%
$23.66Pivot R1+2.2%
$23.33Pivot+0.7%
$23.16Last close
$22.95Swing low (Nov 6)−0.9%
$22.83Pivot S1−1.4%
$22.0652 week low−4.7%
Indicators
RSI (14)
37.17
Weak, oversold below 30
Neutral
MACD
-1.66
Above its signal line
Bullish
Stochastic
11.3
Near the bottom of its range
Oversold
ADX (14)
30.8
Trending down
Williams %R
-94.0
Oversold below −80, overbought above −20
Oversold
CCI (20)
-111.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−5.2%
Change over 10 sessions
Bearish
ATR (14)
$1.87
Typical daily range, 8.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling, nearing oversold
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNear oversold
VolatilityNormal, 20.1%/day
Key levels
$52.9352 week high+128.5%
$37.22100 day average+60.7%
$35.51200 day average+53.3%
$29.8550 day average+28.9%
$26.36Swing high (Nov 4)+13.8%
$24.9520 day average+7.7%
$23.66Pivot R1+2.2%
$23.33Pivot+0.7%
$23.16Last close
$22.95Swing low (Nov 6)−0.9%
$22.83Pivot S1−1.4%
$22.0652 week low−4.7%
Indicators
RSI (14)
31.02
Weak, oversold below 30
Neutral
MACD
-3.32
Below its signal line
Bearish
Stochastic
8.2
Near the bottom of its range
Oversold
ADX (14)
35.6
Trending down
Williams %R
-96.4
Oversold below −80, overbought above −20
Oversold
CCI (20)
-110.1
Oversold below −100, overbought above 100
Oversold
Rate of change
−46.9%
Change over 10 sessions
Bearish
ATR (14)
$4.65
Typical daily range, 20.1% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for RAPP
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how RAPP did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for RAPPHow many large options trades hit RAPP, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in RAPP in the last 90 days.
From SEC Form 4 filings by RAPP's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RAPP is in one of them and how their past RAPP trades turned out.
Rapport Therapeutics is a biotechnology company based in Boston, Massachusetts, that develops small molecule drugs for neurological and psychiatric disorders. Its lead candidate, RAP-219, is being studied for focal onset seizures, a form of epilepsy, and is also being evaluated for generalized seizures and bipolar mania. The company is also developing an injectable version of that candidate and earlier-stage programs aimed at chronic pain, migraine, and hearing and balance disorders. Its intended market is patients with these conditions and the physicians who treat them.